Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AVINASH SINGH

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1043763832
CMS profile
11459597
Location
NEW YORK, NY

General Payments · PY2022–2024

$1,473.22

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$666.38

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $666.38 12

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
CVRx Inc. $300.51 4
Acerta Pharma LLC $128.88 1
ABIOMED $123.88 1
NOVARTIS PHARMACEUTICALS CORPORATION $95.89 5
Medtronic, Inc. $17.22 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $124.15 1
PY2023 $682.69 19
PY2024 $666.38 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $123.88 02/29/2024 Food and Beverage Undisputed 01/23/2026 1142258316 CMS
AstraZeneca Pharmaceuticals LP $128.88 08/08/2024 Food and Beverage Undisputed 01/23/2026 1104467684 CMS
CVRx, Inc. $114.38 01/01/2024 Food and Beverage Undisputed 01/23/2026 1138614937 CMS
CVRx, Inc. $23.25 01/01/2024 Food and Beverage Undisputed 01/23/2026 1138614939 CMS
CVRx, Inc. $14.12 01/09/2024 Food and Beverage Undisputed 01/23/2026 1138614941 CMS
CVRx, Inc. $148.76 04/30/2024 Food and Beverage Undisputed 01/23/2026 1138614943 CMS
Medtronic, Inc. $17.22 07/09/2024 Food and Beverage Undisputed 01/23/2026 1117042483 CMS
Novartis Pharmaceuticals Corporation $22.09 01/11/2024 Food and Beverage Undisputed 01/23/2026 1087232105 CMS
Novartis Pharmaceuticals Corporation $20.42 02/13/2024 Food and Beverage Undisputed 01/23/2026 1087232103 CMS
Novartis Pharmaceuticals Corporation $16.10 04/16/2024 Food and Beverage Undisputed 01/23/2026 1087232107 CMS
Novartis Pharmaceuticals Corporation $18.04 08/15/2024 Food and Beverage Undisputed 01/23/2026 1087232111 CMS
Novartis Pharmaceuticals Corporation $19.24 09/03/2024 Food and Beverage Undisputed 01/23/2026 1087232113 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.